Edition:
United Kingdom

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

1.86USD
9:00pm BST
Change (% chg)

$0.06 (+3.33%)
Prev Close
$1.80
Open
$1.85
Day's High
$1.86
Day's Low
$1.83
Volume
231
Avg. Vol
2,586
52-wk High
$4.49
52-wk Low
$1.67

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the research and development of certain pharmaceutical products for use in humans that includes the use of the Company's platform technologies that enables the creation of drug therapies primarily for orphan indications. The... (more)
No analyst recommendations are available for .

Overall

Beta: 1.20
Market Cap(Mil.): $16.39
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 237.88 32.90
EPS (TTM): -0.42 -- --
ROI: -19.79 -7.38 12.74
ROE: -23.60 -10.11 14.64

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $66.57 +0.01

Earnings vs. Estimates